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Increasing evidence indicates that the transcrip-
tional machinery can influence the efficiency of
splicing as well as splice-site selection. Surprisingly,
it has now been demonstrated that splicing compo-
nents influence the efficiency of transcription. This
mutual stimulation has important implications for the
regulation of gene expression.
Splicing of a pre-mRNA in a eukaryotic cell is tightly
coupled to transcription, and most likely takes place
as the nascent transcript emerges from RNA poly-
merase II. Although transcription and splicing can
occur independently in vitro, the coupling of these
steps affords their coordination as well as the oppor-
tunity for one process to influence the other. The car-
boxyl-terminal domain (CTD) of polymerase II, which
consists of tandem repeats of the heptapeptide con-
sensus sequence YSPTSPS, is important for the cou-
pling of transcription and splicing, as well as for the
formation of a 5′-cap and the 3′-end cleavage of tran-
scripts (reviewed in [1–4]). 
A number of pre-mRNA processing components, as
well as proteins related to splicing factors, have been
identified in association with the CTD as well as other
components of the transcription machinery, support-
ing the view that splicing and transcription are closely
coupled. Fong and Zhou [5] have now shown that
basal splicing factors associate with the transcription
elongation factor TAT-SF1, forming a complex that
can stimulate both transcription and splicing (Figure
1). This new study has thus demonstrated for the first
time reciprocal stimulation between transcription and
splicing, indicating that there is much more extensive
coupling between these processes than previously
anticipated.
Early indications that splicing occurs co-transcrip-
tionally came from cytological observations that
introns near the 5′ end of certain transcripts can be
removed before transcription of the gene is completed
(reviewed in [4]). Subsequent in situ hybridization
studies showed that spliced transcripts and their cor-
responding genes frequently co-localize [6–8]. More-
over, it has been demonstrated that splicing factors
are actively recruited to sites of polymerase II tran-
scription from proximal sites that are highly enriched
in splicing factors [9]. Recently, several groups have
shown that there is functional intercommunication
between the transcription and splicing machineries.
At the stage of transcriptional initiation, the levels of
inclusion of the alternatively spliced fibronectin EDA
exon vary when transcription of an EDA-containing
minigene reporter is driven by different promoters [10].
An emerging model suggests that SR proteins
associate with the transcriptional machinery during its
assembly at the promoter; the SR proteins can then be
recruited to the alternatively spliced EDA exon upon its
transcription. SR proteins are a class of splicing factors
which contain an ‘RS domain’ — rich in alternating argi-
nine and serine residues — which is important for medi-
ating protein–protein interactions with the RS domains
of other splicing factors. SR proteins are required for
constitutive and regulated splicing, and are known to
bind to exonic splicing enhancer elements (ESEs), which
promote the recognition of adjacent splice sites. The
ability of specific SR proteins to promote EDA exon
inclusion was shown to be dependent on the promoter
used to drive its transcription [10].
Further consistent with the view that early transcription
complexes play a role in the regulation of splicing, it
was demonstrated that specific transcriptional activa-
tors with differing abilities to stimulate the processiv-
ity of polymerase II can result in different levels of
repression of EDA exon inclusion [11]. The implication
of these studies is that factors operating at the level of
transcription initiation may play an important role in
establishing patterns of splice-site selection. As dis-
cussed below, it is currently unclear whether the CTD
of polymerase II mediates one or more of these effects
of transcription initiation components.
The CTD of polymerase II contains multiple potential
phosphorylation sites within its heptapeptide consen-
sus sequence. The CTD is mostly hypophosphorylated
(polymerase IIa) at the initiation phase of transcription,
becoming hyperphosphorylated (polymerase IIo)
during transcription elongation. CTD phosphorylation
is primarily catalysed  by the Cdk9 subunit of elonga-
tion factor P-TEFb (reviewed in [12]). The first evidence
that the CTD is important for pre-mRNA processing was
provided by Bentley and colleagues [13,14], who
demonstrated that deletion of the CTD prevents effi-
cient capping, splicing and 3′ cleavage in vivo. More
recently, it was shown that the CTD may facilitate
ESE-dependent splicing [15], consistent with it having
a role in mediating the effects of transcription initiation
components on alternative splicing. Moreover, splic-
ing factors, including SR proteins, have been detected
in association with a transcriptionally active ‘holoen-
zyme’ containing polymerase IIa [16], as well as with
polymerase IIo (reviewed in [2,4]). 
A class of RS domain-containing proteins known as
SCAFs — SR-like CTD associated factors — associate
with the polymerase II CTD through a novel domain
and are additional candidates for bridging to RS-
domain-containing splicing factors, although a role for
SCAFs in splicing has not been demonstrated to date.
A recent genome-wide survey of proteins containing
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RS domains has revealed the existence of additional
RS domain-containing proteins that are related to
transcription factors, further suggesting that there
may be extensive contacts between transcription and
splicing processes [17]. Experimental evidence that
RS domain proteins have a role in coupling these
processes has come from a recent study [18] demon-
strating that PGC-1, an RS domain-containing tran-
scriptional coactivator of nuclear receptors, can
influence splice-site selection.
The evidence for reciprocal stimulation between
splicing and transcription machineries reported
recently by Fong and Zhou [5] has provided an impor-
tant extension to our understanding of how these
processes influence each other. Their work has
shown that the transcriptional elongation factor TAT-
SF1 interacts with the carboxyl terminus of the
CYCT1 subunit of the P-TEFb CTD kinase (CYCT1-C).
Anti-TAT-SF1 immunoprecipitates were shown to
specifically restore transcription to a nuclear extract
that had been depleted with immobilized CYCT1-C.
This extract is quantitatively depleted of TAT-SF1, but
not of the elongation factors SPT5 and RAP30 or
polymerase II. Given its homology to the U2 snRNP-
associated yeast protein CUS2, Fong and Zhou [5]
asked whether TAT-SF1 binds splicing factors and
whether such an interaction might provide a role in
promoting elongation. The U1 snRNP-specific protein
U1-70K, the U2 snRNP-specific protein U2B′′ and the
common Sm proteins B and B′ were all found to inter-
act with Flag-TAT-SF1 in co-immunoprecipitation
experiments. Furthermore, all five U snRNAs were
detected in TAT-SF1 immunoprecipitates analyzed by
northern blotting.
Fong and Zhou [5] tested the ability of the TAT-
SF1-snRNP-containing complex to stimulate tran-
scription as well as to promote splicing. TAT-SF1
complex treated with micrococcal nuclease was
unable to restore transcription to the CYCT1-C-
depleted nuclear extract, indicating that the snRNP
components within the complex are important. This
observation was confirmed by showing that nuclear
extract depleted of multiple snRNPs, or of U2 snRNP,
had reduced transcriptional activity, which could be
restored when the TAT-SF1 complex was added back
to the reaction. In the reciprocal experiment, in vitro
splicing activity was restored to nuclease-treated nuclear
extract when incubated with TAT-SF1 complex, indi-
cating that all of the snRNP components required are
present in the complex.
These observations led Fong and Zhou [5] to test
whether splicing can stimulate transcription in a
coupled transcription–splicing reaction. Nascent
splicing substrates lacking a wild-type 3′ splice site,
5′ splice site or intron-polypyrimidine tract were less
efficiently transcribed than the corresponding wild-
type substrates. This is another example of how
snRNP components can influence transcription. The
7SK snRNA was recently shown by Zhou and col-
leagues [19] and Bensaude’s group [20] to associate
with P-TEFb and negatively regulate its CTD kinase
activity. The results together indicate that several dif-
ferent snRNPs can positively or negatively modulate
transcription through associations with the P-TEFb
elongation factor.
Why is it important for the splicing machinery to
influence transcription elongation? Assembly of splic-
ing factors at nascent 5′ splice sites might help the
transcriptional machinery transcribe through an intron
sequence, which can range in length from hundreds
to tens of thousands of bases. This reciprocal cou-
pling probably serves to maintain the phosphorylation
status of the CTD by facilitating the recruitment of
P-TEFb. As hyperphosphorylated CTD is associated
with highly processive, elongating polymerase II, this
may ensure efficient transcription through long
introns, and also facilitate further associations with
processing factors that depend on a hyperphospho-
rylated CTD (Figure 1). Thus, mutual stimulation of
transcription and splicing ensures that they act as a
close couple, thereby facilitating efficient gene
expression.
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Figure 1. A model for the role of a TAT-
SF1–snRNP-containing complex and
other factors in the coupling of
transcription and splicing.
Different pre-mRNA processing compo-
nents (yellow) can associate with the CTD
of RNA polymerase II (purple) and stimu-
late 5′ cap formation, splicing and 3′ pro-
cessing (not shown). Splicing factors
(including U1 and other snRNPs) associ-
ating with the nascent transcript may, in
turn, stimulate highly processive tran-
scription by facilitating the recruitment of
the CTD kinase P-TEFb, through interac-
tions mediated by TAT-SF1 which inter-
acts with both snRNPs and P-TEFb.
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